Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A review of clinical experience with paclitaxel extravasations.

Literature DB >> 12690542

A review of clinical experience with paclitaxel extravasations.

Abstract

Paclitaxel is a novel anti-neoplastic with a wide spectrum of activity in various malignant tumors. Extravasation of chemotherapy drugs is a widely feared adverse event in oncology patients. A Medline search between 1966 and October 2002 was conducted to identify case reports related to paclitaxel extravasation, as well as a bibliography screening of identified papers. The goal of this work is to summarize the available reports of paclitaxel extravasation and assess its vesicant potential. Additionally, management strategies for extravasation events due to paclitaxel are assessed.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2003 PMID： 12690542 DOI： 10.1007/s00520-003-0441-0

Source DB: PubMed Journal: Support Care Cancer ISSN： 0941-4355 Impact factor: 3.603

34 in total

1. Skin ulceration potential of paclitaxel in a mouse skin model in vivo.

Authors: G Bertelli; M A Cafferata; A Ardizzoni; A Gozza; R Rosso; D Dini
Journal: Cancer Date: 1997-06-01 Impact factor: 6.860

2. Paclitaxel-induced cutaneous toxicity.

Authors: T Berghmans; J Klastersky
Journal: Support Care Cancer Date: 1995-05 Impact factor: 3.603

3. Case report of Taxol administration via central vein producing a recall reaction at a site of prior Taxol extravasation.

Authors: J L Meehan; J R Sporn
Journal: J Natl Cancer Inst Date: 1994-08-17 Impact factor: 13.506

4. Taxol and radiation recall dermatitis.

Authors: V T Raghavan; W D Bloomer; D E Merkel
Journal: Lancet Date: 1993-05-22 Impact factor: 79.321

5. Therapy of local toxicities caused by extravasation of cancer chemotherapeutic drugs.

Authors: R J Ignoffo; M A Friedman
Journal: Cancer Treat Rev Date: 1980-03 Impact factor: 12.111

Review 6. Vesicant extravasation: myths and realities.

Authors: D M Boyle; C Engelking
Journal: Oncol Nurs Forum Date: 1995 Jan-Feb Impact factor: 2.172

7. Hyaluronidase as an antidote to extravasation of Vinca alkaloids: clinical results.

Authors: G Bertelli; D Dini; G B Forno; A Gozza; S Silvestro; M Venturini; R Rosso; P Pronzato
Journal: J Cancer Res Clin Oncol Date: 1994 Impact factor: 4.553

8. Skin ulceration potential without therapeutic anticancer activity for epipodophyllotoxin commercial diluents.

Authors: R T Dorr; D S Alberts
Journal: Invest New Drugs Date: 1983 Impact factor: 3.850

9. Paclitaxel-induced "recall" soft tissue ulcerations occurring at the site of previous subcutaneous administration of paclitaxel in low doses.

Authors: A du Bois; F G Kommoss; J Pfisterer; H J Lück; H G Meerpohl
Journal: Gynecol Oncol Date: 1996-01 Impact factor: 5.482

10. Experience with subcutaneous infusion ports in three hundred patients.

Authors: T E Brothers; L K Von Moll; J E Niederhuber; J A Roberts; S Walker-Andrews; W D Ensminger
Journal: Surg Gynecol Obstet Date: 1988-04

6 in total

Review 1. Overview, prevention and management of chemotherapy extravasation.

Authors: Firas Y Kreidieh; Hiba A Moukadem; Nagi S El Saghir
Journal: World J Clin Oncol Date: 2016-02-10

Review 2. Dermatological adverse events with taxane chemotherapy.

Authors: Vincent Sibaud; Nicole R Lebœuf; Henri Roche; Viswanath R Belum; Laurence Gladieff; Marion Deslandres; Marion Montastruc; Audrey Eche; Emmanuelle Vigarios; Florence Dalenc; Mario E Lacouture
Journal: Eur J Dermatol Date: 2016-10-01 Impact factor: 3.328